Chunbo (A27828) Q1 2025 earnings summary

Executive summary

• Revenue for Q1 2025 was KRW 35.6 billion, down 10% year-over-year, but operating profit turned positive at KRW 2.8 billion compared to an operating loss in the prior year.

• Net income attributable to owners was KRW 0.9 billion, a significant improvement from a net loss of KRW 23.6 billion in Q1 2024.

• The company’s main business areas are electronic materials, secondary battery materials, pharmaceutical intermediates, and fine chemicals.

Financial highlights

• Gross profit for Q1 2025 was KRW 5.3 billion, with a gross margin of 15.0%.

• Operating profit margin improved to 7.9% from a negative margin in the previous year.

• Cash and cash equivalents increased to KRW 29.6 billion from KRW 15.9 billion at year-end 2024.

• Total assets at March 31, 2025, were KRW 881.8 billion, with total equity of KRW 415.4 billion.

• Net debt to capital ratio improved to 50.4% from 57.6% at year-end 2024.

Outlook and guidance

• The company aims to maintain a stable capital structure and minimize capital costs while maximizing shareholder value.

• Dividend policy is under review to enhance shareholder returns, with flexibility for both interim and year-end dividends.